BioSpace News Archive

Goldfinch Bio, a company singularly focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that Anthony Johnson, M.D., president and chief executive officer, will present a corporate overview at BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference on Friday, March 23, 2018 at 11:30 am Eastern Time.

Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced UCB has elected to exclusively license an undisclosed drug target for inflammatory diseases.

Homelessness is a crisis in the Seattle area as more than 11,600 people are without a place to call home.

DaVita Kidney Care, a division of DaVita Inc. celebrates Robert Provenzano, M.D., FACP, FASN, for receiving the Distinguished Nephrology Service Award from the Renal Physicians Association (RPA) at its annual meeting last week in Orlando, Florida.

Expect U.S. regulatory submission for diabetic retinopathy later this year.

Researchers sought to identify a lead candidate for the treatment of Clostridium difficile (C. difficile) infections based on the lantibiotic Mutacin 1140.

ShangPharma Innovation Inc., a global venture capital firm focused on filling the critical investment gap that exists for the earliest-stage therapeutic breakthroughs, has expanded its life science incubator by nearly 40 percent and updated the facility with additional state-of-the-art laboratory infrastructure and conferencing space.

Proceeds to Support Advancement of Pipeline into Clinical Studies

Record 4Q 2017 Revenue of $1.6 Million; growth of 88% Record 2017 Revenue of $5.2 Million; growth of 84%

Federal Equipment Company, the established pharmaceutical manufacturing and packaging equipment resource, teams up with Techceuticals and IMA Active to provide tablet manufacturing training and equipment demonstrations in April and May of 2018.